Sabby Management’s T2 Biosystems, Inc TTOO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,489
Closed -$31.7K 111
2023
Q2
$31.7K Sell
4,489
-3,007
-40% -$69.2K 0.03% 77
2023
Q1
$345K Buy
+7,496
New +$818K 0.3% 35
2016
Q2
Sell
-29
Closed -$1.43M 341
2016
Q1
$1.43M Sell
29
-17
-37% -$751K 0.07% 130
2015
Q4
$2.52M Buy
46
+15
+48% +$809K 0.14% 106
2015
Q3
$1.35M Buy
31
+12
+63% +$797K 0.06% 204
2015
Q2
$1.58M Sell
19
-13
-41% -$1.13M 0.06% 192
2015
Q1
$2.51M Buy
32
+5
+19% +$464K 0.1% 126
2014
Q4
$2.57K Buy
27
+6
+29% +$495K 0.08% 107
2014
Q3
$1.91K Buy
+21
New +$1.95M 0.07% 113

Other funds holding TTOO

Sabby Management's TTOO Position: Q3 2023 in Review

Sabby Management sold out of T2 Biosystems, Inc (TTOO) in Q3 2023, closing a stake of 4,489 shares — an estimated $31.7K sold.

Sabby Management first reported a position in TTOO in Q3 2014 and held it in 9 quarters. The position peaked at $2.52M in Q4 2015. 40 funds tracked by Wall St. Rank hold TTOO as of Q3 2023.

  • Sabby Management reported no remaining T2 Biosystems, Inc position as of Q3 2023 after selling out during the quarter.
  • Sabby Management sold 4,489 T2 Biosystems, Inc shares in Q3 2023, an estimated $31.7K.
  • Sabby Management first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 9 quarters.
  • Sabby Management's T2 Biosystems, Inc position peaked at $2.52M in Q4 2015.
  • 40 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2023.

Based on Sabby Management's 13F filing for Q3 2023, filed 14 Nov 2023.